These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 23196842)

  • 21. Gut microbiota transplantation from db/db mice induces diabetes-like phenotypes and alterations in Hippo signaling in pseudo germ-free mice.
    Yu F; Jiang R; Han W; Zhan G; Xu X; Jiang X; Wang L; Xiang S; Zhou Q; Liu C; Zhu B; Hua F; Yang C
    Aging (Albany NY); 2020 Nov; 12(23):24156-24167. PubMed ID: 33223509
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hippo pathway coactivators Yap and Taz are required to coordinate mammalian liver regeneration.
    Lu L; Finegold MJ; Johnson RL
    Exp Mol Med; 2018 Jan; 50(1):e423. PubMed ID: 29303509
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of Hippo pathway by mitogenic growth factors via phosphoinositide 3-kinase and phosphoinositide-dependent kinase-1.
    Fan R; Kim NG; Gumbiner BM
    Proc Natl Acad Sci U S A; 2013 Feb; 110(7):2569-74. PubMed ID: 23359693
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overexpression of Rac GTPase Activating Protein 1 Contributes to Proliferation of Cancer Cells by Reducing Hippo Signaling to Promote Cytokinesis.
    Yang XM; Cao XY; He P; Li J; Feng MX; Zhang YL; Zhang XL; Wang YH; Yang Q; Zhu L; Nie HZ; Jiang SH; Tian GA; Zhang XX; Liu Q; Ji J; Zhu X; Xia Q; Zhang ZG
    Gastroenterology; 2018 Oct; 155(4):1233-1249.e22. PubMed ID: 30009820
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytokinesis involves a nontranscriptional function of the Hippo pathway effector YAP.
    Bui DA; Lee W; White AE; Harper JW; Schackmann RC; Overholtzer M; Selfors LM; Brugge JS
    Sci Signal; 2016 Mar; 9(417):ra23. PubMed ID: 26933062
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Hippo/YAP pathway interacts with EGFR signaling and HPV oncoproteins to regulate cervical cancer progression.
    He C; Mao D; Hua G; Lv X; Chen X; Angeletti PC; Dong J; Remmenga SW; Rodabaugh KJ; Zhou J; Lambert PF; Yang P; Davis JS; Wang C
    EMBO Mol Med; 2015 Nov; 7(11):1426-49. PubMed ID: 26417066
    [TBL] [Abstract][Full Text] [Related]  

  • 27. YAP mediates the interaction between the Hippo and PI3K/Akt pathways in mesangial cell proliferation in diabetic nephropathy.
    Qian X; He L; Hao M; Li Y; Li X; Liu Y; Jiang H; Xu L; Li C; Wu W; Du L; Yin X; Lu Q
    Acta Diabetol; 2021 Jan; 58(1):47-62. PubMed ID: 32816106
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CDK5RAP2 interaction with components of the Hippo signaling pathway may play a role in primary microcephaly.
    Sukumaran SK; Stumpf M; Salamon S; Ahmad I; Bhattacharya K; Fischer S; Müller R; Altmüller J; Budde B; Thiele H; Tariq M; Malik NA; Nürnberg P; Baig SM; Hussain MS; Noegel AA
    Mol Genet Genomics; 2017 Apr; 292(2):365-383. PubMed ID: 28004182
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assembly and activation of the Hippo signalome by FAT1 tumor suppressor.
    Martin D; Degese MS; Vitale-Cross L; Iglesias-Bartolome R; Valera JLC; Wang Z; Feng X; Yeerna H; Vadmal V; Moroishi T; Thorne RF; Zaida M; Siegele B; Cheong SC; Molinolo AA; Samuels Y; Tamayo P; Guan KL; Lippman SM; Lyons JG; Gutkind JS
    Nat Commun; 2018 Jul; 9(1):2372. PubMed ID: 29985391
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Upregulation of miR-181c contributes to chemoresistance in pancreatic cancer by inactivating the Hippo signaling pathway.
    Chen M; Wang M; Xu S; Guo X; Jiang J
    Oncotarget; 2015 Dec; 6(42):44466-79. PubMed ID: 26561204
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adhesion glycoprotein CD44 functions as an upstream regulator of a network connecting ERK, AKT and Hippo-YAP pathways in cancer progression.
    Yu S; Cai X; Wu C; Wu L; Wang Y; Liu Y; Yu Z; Qin S; Ma F; Thiery JP; Chen L
    Oncotarget; 2015 Feb; 6(5):2951-65. PubMed ID: 25605020
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of the Hippo-YAP Pathway by Glucose Sensor O-GlcNAcylation.
    Peng C; Zhu Y; Zhang W; Liao Q; Chen Y; Zhao X; Guo Q; Shen P; Zhen B; Qian X; Yang D; Zhang JS; Xiao D; Qin W; Pei H
    Mol Cell; 2017 Nov; 68(3):591-604.e5. PubMed ID: 29100056
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hippo signaling dysfunction induces cancer cell addiction to YAP.
    Han H; Yang B; Nakaoka HJ; Yang J; Zhao Y; Le Nguyen K; Bishara AT; Mandalia TK; Wang W
    Oncogene; 2018 Dec; 37(50):6414-6424. PubMed ID: 30068939
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of the hippo signaling pathway in human gastric cancer.
    Zhou GX; Li XY; Zhang Q; Zhao K; Zhang CP; Xue CH; Yang K; Tian ZB
    Asian Pac J Cancer Prev; 2013; 14(9):5199-205. PubMed ID: 24175801
    [TBL] [Abstract][Full Text] [Related]  

  • 35. YAP activation is an early event and a potential therapeutic target in liver cancer development.
    Perra A; Kowalik MA; Ghiso E; Ledda-Columbano GM; Di Tommaso L; Angioni MM; Raschioni C; Testore E; Roncalli M; Giordano S; Columbano A
    J Hepatol; 2014 Nov; 61(5):1088-96. PubMed ID: 25010260
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hippo Deficiency Leads to Cardiac Dysfunction Accompanied by Cardiomyocyte Dedifferentiation During Pressure Overload.
    Ikeda S; Mizushima W; Sciarretta S; Abdellatif M; Zhai P; Mukai R; Fefelova N; Oka SI; Nakamura M; Del Re DP; Farrance I; Park JY; Tian B; Xie LH; Kumar M; Hsu CP; Sadayappan S; Shimokawa H; Lim DS; Sadoshima J
    Circ Res; 2019 Jan; 124(2):292-305. PubMed ID: 30582455
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting the Hippo pathway: Clinical implications and therapeutics.
    Ye S; Eisinger-Mathason TS
    Pharmacol Res; 2016 Jan; 103():270-8. PubMed ID: 26678601
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A YAP/TAZ-induced feedback mechanism regulates Hippo pathway homeostasis.
    Moroishi T; Park HW; Qin B; Chen Q; Meng Z; Plouffe SW; Taniguchi K; Yu FX; Karin M; Pan D; Guan KL
    Genes Dev; 2015 Jun; 29(12):1271-84. PubMed ID: 26109050
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hippo-YAP signaling pathway: A new paradigm for cancer therapy.
    Ma Y; Yang Y; Wang F; Wei Q; Qin H
    Int J Cancer; 2015 Nov; 137(10):2275-86. PubMed ID: 25042563
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Actin polymerization-enhancing drugs promote ovarian follicle growth mediated by the Hippo signaling effector YAP.
    Cheng Y; Feng Y; Jansson L; Sato Y; Deguchi M; Kawamura K; Hsueh AJ
    FASEB J; 2015 Jun; 29(6):2423-30. PubMed ID: 25690654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.